Effects of Palm Stearin versus Butter in the Context of Low-Carbohydrate/High-Fat and High-Carbohydrate/Low-Fat Diets on Circulating Lipids in a Controlled Feeding Study in Healthy Humans.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
05 Jun 2021
Historique:
received: 15 04 2021
revised: 31 05 2021
accepted: 02 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 28 7 2021
Statut: epublish

Résumé

Foods rich in saturated fatty acids (SFAs) have been discouraged by virtue of their cholesterol-raising potential, but this effect is modulated by the food source and background level of carbohydrate. We aimed to compare the consumption of palm stearin (PS) versus butter on circulating cholesterol responses in the setting of both a low-carbohydrate/high-fat (LC/HF) and high-carbohydrate/low-fat (HC/LF) diet in healthy subjects. We also explored effects on plasma lipoprotein particle distribution and fatty acid composition. We performed a randomized, controlled-feeding, cross-over study that compared a PS- versus a Butter-based diet in a group of normocholesterolemic, non-obese adults. A controlled canola oil-based 'Run-In' diet preceded the experimental PS and Butter diets. All diets were eucaloric, provided for 3-weeks, and had the same macronutrient distribution but varied in primary fat source (40% of the total fat). The same Run-In and cross-over experiments were done in two separate groups who self-selected to either a LC/HF ( Compared to PS, Butter resulted in higher LDL-C in both the LC/HF (13.4%, These results demonstrate that Butter raises LDL-C relative to PS in healthy normocholesterolemic adults regardless of background variations in carbohydrate and fat, an effect primarily attributed to larger cholesterol-rich LDL particles.

Sections du résumé

BACKGROUND BACKGROUND
Foods rich in saturated fatty acids (SFAs) have been discouraged by virtue of their cholesterol-raising potential, but this effect is modulated by the food source and background level of carbohydrate.
OBJECTIVE OBJECTIVE
We aimed to compare the consumption of palm stearin (PS) versus butter on circulating cholesterol responses in the setting of both a low-carbohydrate/high-fat (LC/HF) and high-carbohydrate/low-fat (HC/LF) diet in healthy subjects. We also explored effects on plasma lipoprotein particle distribution and fatty acid composition.
METHODS METHODS
We performed a randomized, controlled-feeding, cross-over study that compared a PS- versus a Butter-based diet in a group of normocholesterolemic, non-obese adults. A controlled canola oil-based 'Run-In' diet preceded the experimental PS and Butter diets. All diets were eucaloric, provided for 3-weeks, and had the same macronutrient distribution but varied in primary fat source (40% of the total fat). The same Run-In and cross-over experiments were done in two separate groups who self-selected to either a LC/HF (
RESULTS RESULTS
Compared to PS, Butter resulted in higher LDL-C in both the LC/HF (13.4%,
CONCLUSIONS CONCLUSIONS
These results demonstrate that Butter raises LDL-C relative to PS in healthy normocholesterolemic adults regardless of background variations in carbohydrate and fat, an effect primarily attributed to larger cholesterol-rich LDL particles.

Identifiants

pubmed: 34198888
pii: nu13061944
doi: 10.3390/nu13061944
pmc: PMC8226735
pii:
doi:

Substances chimiques

Dietary Carbohydrates 0
Dietary Fats 0
Lipids 0
Palm Oil 5QUO05548Z
Butter 8029-34-3
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Malaysian Palm Oil Board
ID : 60049325

Références

Eur Heart J. 2020 Jun 21;41(24):2313-2330
pubmed: 32052833
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Lipids. 2010 Oct;45(10):947-62
pubmed: 20820932
PLoS One. 2014 Nov 21;9(11):e113605
pubmed: 25415333
J Nutr. 2015 Jul;145(7):1549-58
pubmed: 25995283
Diabetologia. 2005 Oct;48(10):1999-2005
pubmed: 16132958
J Am Coll Cardiol. 2020 Aug 18;76(7):844-857
pubmed: 32562735
Am J Clin Nutr. 2003 Jul;78(1):91-8
pubmed: 12816776
Am J Clin Nutr. 2015 Aug;102(2):309-15
pubmed: 26135349
Am J Clin Nutr. 2010 Mar;91(3):535-46
pubmed: 20071648
J Oleo Sci. 2018;67(6):697-706
pubmed: 29863090
Circulation. 1999 Feb 16;99(6):779-85
pubmed: 9989963
JAMA. 2006 Feb 8;295(6):655-66
pubmed: 16467234
Am J Clin Nutr. 2008 Jul;88(1):203-9
pubmed: 18614742
Arterioscler Thromb Vasc Biol. 2014 May;34(5):1069-77
pubmed: 24558110
Clin Chem. 2008 Aug;54(8):1307-16
pubmed: 18515257
BMJ. 1997 Jan 11;314(7074):112-7
pubmed: 9006469
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):196-201
pubmed: 24233487
Lancet. 2017 Nov 4;390(10107):2050-2062
pubmed: 28864332
Am J Clin Nutr. 2014 Jun;99(6):1331-50
pubmed: 24717342
Nutr Metab (Lond). 2007 Jul 12;4:16
pubmed: 17625019
JCI Insight. 2019 Jun 20;4(12):
pubmed: 31217353
Circulation. 2017 Jul 18;136(3):e1-e23
pubmed: 28620111
Proc Natl Acad Sci U S A. 1918 Dec;4(12):370-3
pubmed: 16576330
Am J Clin Nutr. 2011 Dec;94(6):1426-32
pubmed: 22071711
Lipids. 2009 Apr;44(4):297-309
pubmed: 19082851
Lancet Diabetes Endocrinol. 2014 Oct;2(10):810-8
pubmed: 25107467
Oxid Med Cell Longev. 2017;2017:1273042
pubmed: 28572872
Circulation. 2015 Dec 8;132(23):2220-9
pubmed: 26408274
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
Eur Heart J. 2017 Aug 21;38(32):2459-2472
pubmed: 28444290
Lipids Health Dis. 2015 Oct 29;14:137
pubmed: 26510458
Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):169-78
pubmed: 7749822
Am Heart J. 2008 Nov;156(5):965-74
pubmed: 19061714
Am J Clin Nutr. 2010 Mar;91(3):502-9
pubmed: 20089734

Auteurs

Parker N Hyde (PN)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.
Department of Kinesiology, University of North Georgia, Dahlonega, GA 30597, USA.

Teryn N Sapper (TN)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Richard A LaFountain (RA)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Madison L Kackley (ML)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Alex Buga (A)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Brandon Fell (B)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Christopher D Crabtree (CD)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Stephen D Phinney (SD)

Virta Health, San Francisco, CA 94105, USA.

Vincent J Miller (VJ)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Sarah M King (SM)

Departments of Pediatrics and Medicine, University of California, San Francisco, CA 94609, USA.

Ronald M Krauss (RM)

Departments of Pediatrics and Medicine, University of California, San Francisco, CA 94609, USA.

William J Kraemer (WJ)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Jeff S Volek (JS)

Department of Human Sciences, The Ohio State University, 305 Annie & John Glenn Ave, Columbus, OH 43210, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH